Citations (104)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jing Wang, Christian Karime, Umair Majeed, Jason S. Starr, Mitesh J. Borad & Hani M. Babiker. (2023) Targeting leukemia inhibitory factor in pancreatic adenocarcinoma. Expert Opinion on Investigational Drugs 32:5, pages 387-399.
Read now
Read now
Dmytro Starenki, Seung-Keun Hong, Pui-Kei Wu & Jong-In Park. (2017) Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells. Cancer Biology & Therapy 18:7, pages 473-483.
Read now
Read now
Santosh K. Ghosh, Thomas S. McCormick, Betty L. Eapen, Elizabeth Yohannes, Mark R. Chance & Aaron Weinberg. (2013) Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects. Epigenetics 8:7, pages 703-709.
Read now
Read now
Scott N Pinchot, Rebecca S Sippel & Herbert Chen. (2008) Multi-targeted approach in the treatment of thyroid cancer. Therapeutics and Clinical Risk Management 4:5, pages 935-947.
Read now
Read now
Articles from other publishers (100)
Paulina Wigner, Michał Bijak & Joanna Saluk-Bijak. (2022) Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment. Nutrients 14:6, pages 1132.
Crossref
Crossref
Megan M. Jorgensen & Pilar de la Puente. (2022) Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer. Biomolecules 12:2, pages 217.
Crossref
Crossref
Seung-Keun Hong, Dmytro Starenki, Oleta T. Johnson, Jason E. Gestwicki & Jong-In Park. (2022) Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells. International Journal of Molecular Sciences 23:3, pages 1063.
Crossref
Crossref
Andrew E. Becker, Pui-Kei Wu & Jong-In Park. (2021) eIF5A-Independent Role of DHPS in p21CIP1 and Cell Fate Regulation. International Journal of Molecular Sciences 22:24, pages 13187.
Crossref
Crossref
Rebecca Caeser, Christopher Hulton, Emily Costa, Vidushi Durani, Megan Little, Xiaoping Chen, Sam E. Tischfield, Marina Asher, Faruk Erdem Kombak, Shweta S. Chavan, Nisargbhai S. Shah, Metamia Ciampricotti, Elisa de Stanchina, John T. Poirier, Charles M. Rudin & Triparna Sen. (2021) MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer. iScience 24:11, pages 103224.
Crossref
Crossref
Giovanni Manzo. (2021) Specific and Aspecific Molecular Checkpoints as Potential Targets for Dismantling Tumor Hierarchy and Preventing Relapse and Metastasis Through Shielded Cytolytic Treatments. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Cen Zhang, Juan Liu, Jianming Wang, Wenwei Hu & Zhaohui Feng. (2021) The emerging role of leukemia inhibitory factor in cancer and therapy. Pharmacology & Therapeutics 221, pages 107754.
Crossref
Crossref
Sean A. Hunter, Brianna J. McIntosh, Yu Shi, R. Andres Parra Sperberg, Chie Funatogawa, Louai Labanieh, Erin Soon, Hannah C. Wastyk, Nishant Mehta, Catherine Carter, Tony Hunter & Jennifer R. Cochran. (2021) An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy. Communications Biology 4:1.
Crossref
Crossref
Chandler S. Callaway, Andrea E. Delitto, Andrew C. D’Lugos, Rohan Patel, Rachel L. Nosacka, Daniel Delitto, Michael R. Deyhle, Jose G. Trevino, Sarah M. Judge & Andrew R. Judge. (2019) IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy. Cancers 11:12, pages 1863.
Crossref
Crossref
B. B. Guda, V. V. Pushkarev, O. I. Kovzun, V. P. Pushkarev & M. D. Tronko. (2019) Токсичність МАРК у карциномах щитоподібної залози. Механізми пригнічення сигнального каскаду (огляд літератури та власних даних). Шпитальна хірургія. Журнал імені Л. Я. Ковальчука:3, pages 84-96.
Crossref
Crossref
Giovanni Manzo. (2019) Similarities Between Embryo Development and Cancer Process Suggest New Strategies for Research and Therapy of Tumors: A New Point of View. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
V. M. Pushkarev, B. B. Guda, V. V. Pushkarev & N. D. Tronko. (2018) Oncogene toxicity in thyroid carcinomas and other types of tumors. Cytology and Genetics 52:1, pages 54-61.
Crossref
Crossref
Seung-Keun Hong, Pui-Kei Wu & Jong-In Park. (2018) A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses. Cellular Signalling 42, pages 11-20.
Crossref
Crossref
Syed Azmal Ali, Gurjeet Kaur, Jai Kumar Kaushik, Dhruba Malakar, Ashok Kumar Mohanty & Sudarshan Kumar. (2017) Examination of pathways involved in leukemia inhibitory factor (LIF)-induced cell growth arrest using label-free proteomics approach. Journal of Proteomics 168, pages 37-52.
Crossref
Crossref
Herbert Chen. (2016) Activation of Mek Alters Morphology and Neuroendocrine Phenotype in Medullary Thyroid Cancer Cell. Endocrinology&Metabolism International Journal 3:5.
Crossref
Crossref
B. B. Guda, V. V. Pushkarev, O. V. Zhuravel, A. Ye. Kovalenko, V. M. Pushkarev, Y. M. Taraschenko & M. D. Tronko. (2016) Protein kinase Akt activity in human thyroid tumors. The Ukrainian Biochemical Journal 88:5, pages 90-95.
Crossref
Crossref
Yong-Hee Rhee, Sang-Hoon Yi, Joo Yeon Kim, Mi-Yoon Chang, A-Young Jo, Jinyoung Kim, Chang-Hwan Park, Je-Yoel Cho, Young-Jin Choi, Woong Sun & Sang-Hun Lee. (2016) Neural stem cells secrete factors facilitating brain regeneration upon constitutive Raf-Erk activation. Scientific Reports 6:1.
Crossref
Crossref
Yan Liu, Shu-Qing Wang, Yue-Hong Long, Su Chen, Yu-Feng Li & Jing-Hua Zhang. (2016) KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway. Oncotarget 7:33, pages 53153-53164.
Crossref
Crossref
B.B. Guda, V.M. Pushkarev, O.V. Zhuravel, A.Ye. Kovalenko, V.V. Pushkarev, Y.M. Tarashchenko, L.Y. Zurnadzhy, O.I. Kovzun & M.D. Tronko. (2016) Expression and activity of extracellular signal-regulated kinase-1/2 (ERK1/2) in normal tissues and human thyroid tumors. Reports of the National Academy of Sciences of Ukraine:1, pages 105-109.
Crossref
Crossref
Sonia Aroui, Bakhta Aouey, Yassine Chtourou, Annie-Claire Meunier, Hamadi Fetoui & Abderraouf Kenani. (2016) Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma. Chemico-Biological Interactions 244, pages 195-203.
Crossref
Crossref
Guilherme Rodrigo Reis Monteiro dos-Santos, Marcio Ribeiro Fontenele, Felipe de Almeida Dias, Pedro Lagerblad de Oliveira, José Luciano Nepomuceno-Silva, Luiz Dione Barbosa de Melo, Helena Maria Marcolla Araujo & Ulisses Gazos Lopes. (2015) Functional studies of TcRjl, a novel GTPase of Trypanosoma cruzi , reveals phenotypes related with MAPK activation during parasite differentiation and after heterologous expression in Drosophila model system. Biochemical and Biophysical Research Communications 467:1, pages 115-120.
Crossref
Crossref
Hongwei Guo, Yabin Cheng, Magdalena Martinka & Kevin McElwee. (2015) High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma. Oncotarget 6:28, pages 25484-25498.
Crossref
Crossref
D Starenki, S-K Hong, R V Lloyd & J-I Park. (2014) Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Oncogene 34:35, pages 4624-4634.
Crossref
Crossref
So Yeun Kim, Alex Mammen, Seung-Jun Yoo, Bongki Cho, Eun-Kyoung Kim, Jong-In Park, Cheil Moon & Gabriele V. Ronnett. (2015) Phosphoinositide and Erk signaling pathways mediate activity-driven rodent olfactory sensory neuronal survival and stress mitigation. Journal of Neurochemistry 134:3, pages 486-498.
Crossref
Crossref
Danielle N. Seto, Susan C. Kandarian & Robert W. Jackman. (2015) A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia. Journal of Biological Chemistry 290:32, pages 19976-19986.
Crossref
Crossref
Chiu Lan Hsieh, Chien-Hong Lin, Kuan Chou Chen, Chiung-Chi Peng & Robert Y. Peng. (2015) The Teratogenicity and the Action Mechanism of Gallic Acid Relating with Brain and Cervical Muscles. PLOS ONE 10:6, pages e0119516.
Crossref
Crossref
Dmytro StarenkiJong-In Park. (2015)
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival
In Vitro
and
In Vivo
. Endocrinology and Metabolism 30:4, pages 593.
Crossref
Crossref
Rebeca Sanz-Pamplona, Antoni Berenguer, David Cordero, David G Molleví, Marta Crous-Bou, Xavier Sole, Laia Paré-Brunet, Elisabet Guino, Ramón Salazar, Cristina Santos, Javier de Oca, Xavier Sanjuan, Francisco Rodriguez-Moranta & Victor Moreno. (2014) Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer. Molecular Cancer 13:1.
Crossref
Crossref
Chryso Kanthou, Gabi U. Dachs, Diane V. Lefley, Andrew J. Steele, Claudia Coralli-Foxon, Sheila Harris, Olga Greco, Sofia A. Dos Santos, Constantino C. Reyes-Aldasoro, William R. English & Gillian M. Tozer. (2014) Tumour Cells Expressing Single VEGF Isoforms Display Distinct Growth, Survival and Migration Characteristics. PLoS ONE 9:8, pages e104015.
Crossref
Crossref
Jean-Philippe Guégan, Frédéric Ezan, Luc Gailhouste, Sophie Langouët & Georges Baffet. (2014) MEK1/2 Overactivation Can Promote Growth Arrest by Mediating ERK1/2-Dependent Phosphorylation of p70S6K. Journal of Cellular Physiology 229:7, pages 903-915.
Crossref
Crossref
Nadiya Sosonkina, Dmytro Starenki & Jong-In Park. (2014) The Role of STAT3 in Thyroid Cancer. Cancers 6:1, pages 526-544.
Crossref
Crossref
Jong-In Park. (2014) Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Frontiers in Biology 9:2, pages 95-103.
Crossref
Crossref
Jared E. Toettcher, Orion D. Weiner & Wendell A. Lim. (2013) Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module. Cell 155:6, pages 1422-1434.
Crossref
Crossref
Dmytro Starenki, Nishant K. Singh, Davin R. Jensen, Francis C. Peterson & Jong-In Park. (2013) Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice. Cancer Letters 339:1, pages 144-151.
Crossref
Crossref
Dmytro Starenki & Jong-In Park. (2013) Mitochondria-Targeted Nitroxide, Mito-CP, Suppresses Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo. The Journal of Clinical Endocrinology & Metabolism 98:4, pages 1529-1540.
Crossref
Crossref
Serena Giunti, Alessandro Antonelli, Andrea Amorosi & Libero Santarpia. (2013) Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma. International Journal of Endocrinology 2013, pages 1-16.
Crossref
Crossref
Joana Pinto CoutoLaura Daly, Ana AlmeidaJeffrey A. KnaufJames A. FaginManuel Sobrinho-Simões, Jorge LimaValdemar MáximoPaula SoaresDavid Lyden & Jacqueline F. Bromberg. (2012) STAT3 negatively regulates thyroid tumorigenesis. Proceedings of the National Academy of Sciences 109:35.
Crossref
Crossref
Su-Mi Jung, Sung-Soo Park, Wun-Jae Kim & Sung-Kwon Moon. (2012) Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells. European Journal of Pharmacology 681:1-3, pages 15-22.
Crossref
Crossref
Istvan AranyDustin K. ReedSamira C. GrifoniKiran Chandrashekar, George W. Booz & Luis A. Juncos. (2012) A novel U-STAT3-dependent mechanism mediates the deleterious effects of chronic nicotine exposure on renal injury. American Journal of Physiology-Renal Physiology 302:6, pages F722-F729.
Crossref
Crossref
Cristina Nogueira-Silva, Paulina Piairo, Emanuel Carvalho-Dias, Francisca O. Peixoto, Rute S. Moura & Jorge Correia-Pinto. (2012) Leukemia Inhibitory Factor in Rat Fetal Lung Development: Expression and Functional Studies. PLoS ONE 7:1, pages e30517.
Crossref
Crossref
Sameer Gupta, Paul F. Engstrom & Steven J. Cohen. (2011) Emerging Therapies for Advanced Gastroenteropancreatic Neuroendocrine Tumors. Clinical Colorectal Cancer 10:4, pages 298-309.
Crossref
Crossref
Seung-Keun Hong, Jin-Hwan Kim, Ming-Fong Lin & Jong-In Park. (2011) The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells. Experimental Cell Research 317:18, pages 2671-2682.
Crossref
Crossref
Ranju Ralhan, Olena Masui, Leroi V. DeSouza, Ajay Matta, Muzafar Macha & K. W. Michael Siu. (2011) Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers. PROTEOMICS 11:12, pages 2363-2376.
Crossref
Crossref
María Cecilia Bottino, Juan Pablo Cerliani, Paola Rojas, Sebastián Giulianelli, Rocío Soldati, Carolina Mondillo, María Alicia Gorostiaga, Omar P. Pignataro, Juan Carlos Calvo, J. Silvio Gutkind, Panomwat Amornphimoltham, Alfredo A. Molinolo, Isabel A. Lüthy & Claudia Lanari. (2010) Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects. Breast Cancer Research and Treatment 126:3, pages 621-636.
Crossref
Crossref
S. Liu, Y. Li, T. Lin, X. Fan, Y. Liang & U. Heemann. (2011) High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via PI3K-independent activation of Akt. Diabetes Research and Clinical Practice 91:2, pages 177-182.
Crossref
Crossref
Barbara Zarebczan & Herbert Chen. (2010) Signaling Mechanisms in Neuroendocrine Tumors as Targets for Therapy. Endocrinology and Metabolism Clinics of North America 39:4, pages 801-810.
Crossref
Crossref
Dumrongkiet Arthan, Seung-Keun Hong & Jong-In Park. (2010) Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells. Cancer Letters 297:1, pages 31-41.
Crossref
Crossref
Li Ning, Herbert Chen & Muthusamy Kunnimalaiyaan. (2010) Focal Adhesion Kinase, a Downstream Mediator of Raf-1 Signaling, Suppresses Cellular Adhesion, Migration, and Neuroendocrine Markers in BON Carcinoid Cells. Molecular Cancer Research 8:5, pages 775-782.
Crossref
Crossref
Ming RuanLarry PedersonElizabeth W. BradleyAna-Maria Bamberger & Merry Jo Oursler. (2010) Transforming Growth Factor-β Coordinately Induces Suppressor of Cytokine Signaling 3 and Leukemia Inhibitory Factor to Suppress Osteoclast Apoptosis. Endocrinology 151:4, pages 1713-1722.
Crossref
Crossref
Tzong-Der Way, Jang-Chang Lee, Daih-Huang Kuo, Ling-Ling Fan, Chi-Hung Huang, Hui-Yi Lin, Po-Chuen Shieh, Po-Tsun Kuo, Chien-Fu Liao, Hanshi Liu & Jung-Yie Kao. (2010)
Inhibition of Epidermal Growth Factor Receptor Signaling by
Saussurea involucrata
, a Rare Traditional Chinese Medicinal Herb, in Human Hormone-Resistant Prostate Cancer PC-3 Cells
. Journal of Agricultural and Food Chemistry 58:6, pages 3356-3365.
Crossref
Crossref
Sylwia Jančík, Jiří Drábek, Danuta Radzioch & Marián Hajdúch. (2010) Clinical Relevance of KRAS in Human Cancers. Journal of Biomedicine and Biotechnology 2010, pages 1-13.
Crossref
Crossref
Marina Trouillas, Claire Saucourt, Bertrand Guillotin, Xavier Gauthereau, Li Ding, Frank Buchholz, Michael Xavier Doss, Agapios Sachinidis, Jurgen Hescheler, Oliver Hummel, Norbert Huebner, Raivo Kolde, Jaak Vilo, Herbert Schulz & Hélène Bœuf. (2009) Three LIF-dependent signatures and gene clusters with atypical expression profiles, identified by transcriptome studies in mouse ES cells and early derivatives. BMC Genomics 10:1.
Crossref
Crossref
Seung-Keun Hong, Seunghee Yoon, Cas Moelling, Dumrongkiet Arthan & Jong-In Park. (2009) Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling. Journal of Biological Chemistry 284:48, pages 33006-33018.
Crossref
Crossref
Lucio Lagunas & Neil A. Clipstone. (2009) Deregulated NFATc1 activity transforms murine fibroblasts via an autocrine growth factor-mediated Stat3-dependent pathway. Journal of Cellular Biochemistry 108:1, pages 237-248.
Crossref
Crossref
Paul B. Romesser, David H. Perlman, Douglas V. Faller, Catherine E. Costello, Mark E. McComb & Gerald V. Denis. (2009) Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma. The American Journal of Pathology 175:1, pages 25-35.
Crossref
Crossref
L. Santarpia, L. Ye & R. F. Gagel. (2009) Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma. Journal of Internal Medicine 266:1, pages 99-113.
Crossref
Crossref
Richard T. KloosMatthew D. RingelMichael V. KnoppNathan C. HallMark KingRobert StevensJiachao LiangPaul E. WakelyJrJrVasyl V. VaskoMotoyasu SajiJennifer RittenberryLai WeiDaria ArbogastMinden CollamoreJohn J. WrightMichael GreverManisha H. Shah. (2009) Phase II Trial of Sorafenib in Metastatic Thyroid Cancer. Journal of Clinical Oncology 27:10, pages 1675-1684.
Crossref
Crossref
Michael LeeJun-Ho AhnKi-Hwan Eum. (2009) The Difference in Biological Properties between Parental and v-Ha-ras Transformed NIH3T3 Cells. Cancer Research and Treatment 41:2, pages 93.
Crossref
Crossref
Scott N. Pinchot, Muthusamy Kunnimalaiyaan, Rebecca S. Sippel & Herbert Chen. (2009) Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions. Journal of Oncology 2009, pages 1-7.
Crossref
Crossref
Terry C. Lairmore & Herbert Chen. 2010. SuperMEN1. SuperMEN1
87
95
.
Eo-Jin Lee, Gi-Seong Moon, Won-Seok Choi, Wun-Jae Kim & Sung-Kwon Moon. (2008) Naringin-induced p21WAF1-mediated G1-phase cell cycle arrest via activation of the Ras/Raf/ERK signaling pathway in vascular smooth muscle cells. Food and Chemical Toxicology 46:12, pages 3800-3807.
Crossref
Crossref
D.-I. Kim, S.-J. Lee, S.-B. Lee, K. Park, W.-J. Kim & S.-K. Moon. (2008) Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis 29:9, pages 1701-1709.
Crossref
Crossref
Rebecca S. Sippel, Muthusamy Kunnimalaiyaan & Herbert Chen. (2008) Current Management of Medullary Thyroid Cancer. The Oncologist 13:5, pages 539-547.
Crossref
Crossref
David Hong, Lei Ye, Robert Gagel, Lakshmi Chintala, Adel K. El Naggar, John Wright & Razelle Kurzrock. (2008) Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib. Molecular Cancer Therapeutics 7:5, pages 1001-1006.
Crossref
Crossref
Beobyi Lee, Se-Jung Lee, Sung-Soo Park, Si-Kwan Kim, Sung-Ryong Kim, Jae-Hyun Jung, Wun-Jae Kim & Sung-Kwon Moon. (2008) Sanguinarine-induced G1-phase arrest of the cell cycle results from increased p27KIP1 expression mediated via activation of the Ras/ERK signaling pathway in vascular smooth muscle cells. Archives of Biochemistry and Biophysics 471:2, pages 224-231.
Crossref
Crossref
Ana Quaglino, Carolina Schere-Levy, Leonardo Romorini, Roberto P Meiss & Edith C Kordon. (2007) Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling. Breast Cancer Research 9:5.
Crossref
Crossref
Muthusamy Kunnimalaiyaan & Herbert Chen. (2007) Tumor Suppressor Role of Notch-1 Signaling in Neuroendocrine Tumors. The Oncologist 12:5, pages 535-542.
Crossref
Crossref
Muthusamy Kunnimalaiyaan, Abram M. Vaccaro, Mary A. Ndiaye & Herbert Chen. (2007) Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Molecular Cancer Therapeutics 6:3, pages 1151-1158.
Crossref
Crossref
Ho Lin, Mei-Chih Chen, Chih-Yuan Chiu, Yuh-Min Song & Shih-Yi Lin. (2007) Cdk5 Regulates STAT3 Activation and Cell Proliferation in Medullary Thyroid Carcinoma Cells. Journal of Biological Chemistry 282:5, pages 2776-2784.
Crossref
Crossref
Hiro Takahashi, Yasuyuki Murase, Takeshi Kobayashi & Hiroyuki Honda. (2007) New cancer diagnosis modeling using boosting and projective adaptive resonance theory with improved reliable index. Biochemical Engineering Journal 33:2, pages 100-109.
Crossref
Crossref
Muthusamy Kunnimalaiyaan, Abram M. Vaccaro, Mary A. Ndiaye & Herbert Chen. (2006) Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer Cells. Journal of Biological Chemistry 281:52, pages 39819-39830.
Crossref
Crossref
Jose SangermanMoo Seung LeeXiao YaoEugene OtengCheng-Hui HsiaoWei LiSima ZeinSolomon F. Ofori-AcquahBetty S. Pace. (2006) Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves γ-globin activation by CREB1 and ATF-2. Blood 108:10, pages 3590-3599.
Crossref
Crossref
Zhong-Zong Pan & Andrew K. Godwin. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Abram Vaccaro, Herbert Chen & Muthusamy Kunnimalaiyaan. (2006) In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer. Anti-Cancer Drugs 17:7, pages 849-853.
Crossref
Crossref
Chang Han, A. Jake Demetris, Donna B. Stolz, Lihong Xu, Kyu Lim & Tong Wu. (2006) Modulation of Stat3 Activation by the Cytosolic Phospholipase A2α and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway. Journal of Biological Chemistry 281:34, pages 24831-24846.
Crossref
Crossref
I. Arany, J.K. Megyesi, B.D. Nelkin & R.L. Safirstein. (2006) STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney International 70:4, pages 669-674.
Crossref
Crossref
Janet R. McColm, Pete Geisen, Lynda J. Peterson & M. Elizabeth Hartnett. (2006) Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis. Experimental Eye Research 83:2, pages 438-446.
Crossref
Crossref
Nuria Moreno-Barriuso, Ana V. López-Malpartida, Flora de Pablo & José G. Pichel. (2006) Alterations in alveolar epithelium differentiation and vasculogenesis in lungs of LIF/IGF-I double deficient embryos. Developmental Dynamics 235:8, pages 2040-2050.
Crossref
Crossref
Ashley Kappes, Abram Vaccaro, Muthusamy Kunnimalaiyaan & Herbert Chen. (2006) ZM336372, A Raf-1 Activator, Inhibits Growth of Pheochromocytoma Cells. Journal of Surgical Research 133:1, pages 42-45.
Crossref
Crossref
Souad Rahmouni, Fabio Cerignoli, Andres Alonso, Toshiya Tsutji, Rachel Henkens, Changjun Zhu, Christine Louis-dit-Sully, Michel Moutschen, Wei Jiang & Tomas Mustelin. (2006) Loss of the VHR dual-specific phosphatase causescell-cycle arrest and senescence. Nature Cell Biology 8:5, pages 524-531.
Crossref
Crossref
S. Cagnol, E. Van Obberghen-Schilling & J.-C. Chambard. (2006) Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death. Apoptosis 11:3, pages 337-346.
Crossref
Crossref
Muthusamy Kunnimalaiyaan & Herbert Chen. (2006) The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?. Anti-Cancer Drugs 17:2, pages 139-142.
Crossref
Crossref
Cheng-Ping Hu, Jun-Tao Feng, Yu-Ling Tang, Jin-Qi Zhu, Min-Juan Lin & Ming-En Yu. (2006) LIF Upregulates Expression of NK-1R in NHBE Cells. Mediators of Inflammation 2006, pages 1-8.
Crossref
Crossref
Jamie J. Van Gompel, Muthusamy Kunnimalaiyaan, Kyle Holen & Herbert Chen. (2005) ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Molecular Cancer Therapeutics 4:6, pages 910-917.
Crossref
Crossref
Herbert ChenMuthusamy KunnimalaiyaanJamie J. Van Gompel. (2005) Medullary Thyroid Cancer: The Functions of raf-1 and Human Achaete-scute Homologue-1. Thyroid 15:6, pages 511-521.
Crossref
Crossref
Shigeaki Suzuki, Toru Yamashita, Kortaro Tanaka, Hidenori Hattori, Kazunobu Sawamoto, Hideyuki Okano & Norihiro Suzuki. (2005) Activation of Cytokine Signaling through Leukemia Inhibitory Factor Receptor (LIFR)/gp130 Attenuates Ischemic Brain Injury in Rats. Journal of Cerebral Blood Flow & Metabolism 25:6, pages 685-693.
Crossref
Crossref
Wyatt Wollmann, Mike L. Goodman, Poornima Bhat-Nakshatri, Hiromitsu Kishimoto, Robert J. GouletJrJr, Sanjana Mehrotra, Akira Morimiya, Sunil Badve & Harikrishna Nakshatri. (2005) The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis 26:5, pages 900-907.
Crossref
Crossref
Eun-Joo Kim, Jong-In Park & Barry D. Nelkin. (2005) IFI16 Is an Essential Mediator of Growth Inhibition, but Not Differentiation, Induced by the Leukemia Inhibitory Factor/JAK/STAT Pathway in Medullary Thyroid Carcinoma Cells. Journal of Biological Chemistry 280:6, pages 4913-4920.
Crossref
Crossref
Mayumi Suzuki, Hidenori Shiraha, Tatsuya Fujikawa, Nobuyuki Takaoka, Naoki Ueda, Yutaka Nakanishi, Kazuko Koike, Akinobu Takaki & Yasushi Shiratori. (2005) Des-γ-carboxy Prothrombin Is a Potential Autologous Growth Factor for Hepatocellular Carcinoma. Journal of Biological Chemistry 280:8, pages 6409-6415.
Crossref
Crossref
Jong-In Park, Christopher J. Strock, Douglas W. Ball & Barry D. Nelkin. (2005) Interleukin-1β can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. Cytokine 29:3, pages 125-134.
Crossref
Crossref
Isao Nozaki, John G Lunz, Susan Specht, Donna B Stolz, Kenichi Taguchi, Vladimir M Subbotin, Noriko Murase & Anthony J Demetris. (2005) Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Laboratory Investigation 85:1, pages 109-123.
Crossref
Crossref
Isao Nozaki, John G. LunzIIIIII, Susan Specht, Jong-In Park, Andrew S. Giraud, Noriko Murase & Anthony J. Demetris. (2004) Regulation and Function of Trefoil Factor Family 3 Expression in the Biliary Tree. The American Journal of Pathology 165:6, pages 1907-1920.
Crossref
Crossref
Kun Do Rhee, Olivier Goureau, Shiming Chen & Xian-Jie Yang. (2004) Cytokine-Induced Activation of Signal Transducer and Activator of Transcription in Photoreceptor Precursors Regulates Rod Differentiation in the Developing Mouse Retina. The Journal of Neuroscience 24:44, pages 9779-9788.
Crossref
Crossref
G.S. Sivko, D.C. Sanford, L.D. Dearth, D. Tang & J.W. DeWille. (2004) CCAAT/enhancer binding protein ? (C/EBP?) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control. Journal of Cellular Biochemistry 93:4, pages 844-856.
Crossref
Crossref
José Leiro, Juan A Arranz, Matilde Yáñez, Florencio M Ubeira, Manuel L Sanmartı́n & Francisco Orallo. (2004) Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. International Immunopharmacology 4:6, pages 763-778.
Crossref
Crossref
Stefan Fernandez, Purnima Jose, Margarita G. Avdiushko, Alan M. Kaplan & Donald A. Cohen. (2004) Inhibition of IL-10 Receptor Function in Alveolar Macrophages by Toll-Like Receptor Agonists. The Journal of Immunology 172:4, pages 2613-2620.
Crossref
Crossref
Natalie A. Sims, Brendan J. Jenkins, Julian M.W. Quinn, Akira Nakamura, Markus Glatt, Matthew T. Gillespie, Matthias Ernst & T. John Martin. (2004) Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. Journal of Clinical Investigation 113:3, pages 379-389.
Crossref
Crossref
L S Steelman, S C Pohnert, J G Shelton, R A Franklin, F E Bertrand & J A McCubrey. (2004) JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18:2, pages 189-218.
Crossref
Crossref
Rebecca S Sippel, Jennifer E Carpenter, Muthusamy Kunnimalaiyaan & Herbert Chen. (2003) The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery 134:6, pages 866-871.
Crossref
Crossref
Sheila M. Nielsen-Preiss, Selina R. Silva & Jennifer M. Gillette. (2003) Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells. Journal of Cellular Biochemistry 90:5, pages 964-975.
Crossref
Crossref